Mid-Con Energy Partners, LP
Mid-Con Energy Partners, LP Acquires Mature Northeastern Oklahoma Properties, Announces Quarterly Cash Distribution, and Schedules Second Quarter 2014 Earnings Release and Conference Call
DALLAS, July 24, 2014 (GLOBE NEWSWIRE) -- Mid-Con Energy Partners, LP (Nasdaq:MCEP) ("Mid-Con Energy"), through its wholly owned subsidiary, Mid-Con Energy Properties, LLC, announces that it has entered into a definitive agreement to acquire net proved reserves estimated at 2.6 million barrels of oil equivalent ("Mmboe") for an aggregate purchase price of approximately $56.5 million, subject to customary post-closing adjustments. The acquisition, expected to close and become effective on August 5, 2014, will be funded with approximately 2.2 million units of MCEP stock and $4.5 million in cash.
Grupo Elektra, S.A.B. de C.V.
GRUPO ELEKTRA ANUNCIA INCREMENTO DE 12% EN EBITDA, A Ps.2,104 MILLONES EN 2T14
—Utilidad de Operación aumenta 16%, a Ps.1,427 millones en el trimestre—
—Ingresos consolidados se incrementan 6%, a Ps.18,265 millones, apoyados por
sólida expansión de 11% en el negocio comercial—
Ciudad de México, 2014-07-25 01:06 CEST (GLOBE NEWSWIRE) -- Grupo Elektra,
S.A.B. de C.V. (BMV: ELEKTRA*; Latibex: XEKT), la empresa de servicios
financieros y de comercio especializado líder en Latinoamérica y mayor
proveedor de préstamos no bancarios de corto plazo en EUA,anunció hoy resultad
Applied Genetic Technologies
AGTC Announces Pricing of Public Offering
GAINESVILLE, Fla., July 24, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC) today announced the pricing of its public offering of 2,000,000 shares of its common stock at a price to the public of $15.00 per share, before underwriting discounts. All of the common stock is being offered by AGTC. In addition, AGTC has granted the underwriters a 30-day option to purchase up to an additional 300,000 shares at the public offering price to cover over-allotments, if any. The company plans to use the net proceeds from the offering to fund preclinical investigation and Phase 1/2 trials of potential product candidates for treatment of wet AMD, to expand its manufacturing capabilities and create a pilot manufacturing group, to in-license, acquire or invest in complementary gene therapy, technologies, products or assets, and for working capital and other general corporate purposes.
El Pollo Loco
El Pollo Loco Holdings, Inc. Prices Its Initial Public Offering
COSTA MESA, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- El Pollo Loco Holdings, Inc. ("El Pollo Loco") (Nasdaq:LOCO) today announced the pricing of its initial public offering of 7,142,857 shares of common stock at a price to the public of $15.00 per share. All of the shares in the offering are being offered by El Pollo Loco. In addition, El Pollo Loco has granted the underwriters a 30-day option to purchase up to an additional 1,071,429 shares. The shares are expected to begin trading on July 25, 2014 on the NASDAQ Global Select Market under the ticker symbol "LOCO". The closing of the offering is expected to occur on July 30, 2014, subject to the satisfaction of customary closing conditions.
BoConcept concludes strategic partnering agreement with Kinetic to boost expansion in China
Realising the global expansion potential of its brand by expanding its
franchise chain – in both established markets and in growth markets in Latin
America and Asia – is a key element in the growth strategy of BoConcept A/S
In line with its strategic focus on improving its growth potential, BoConcept
acquired the master rights to the attractive Chinese market in May 2013. At the
same time, the company set up a new dedicated market organisation, which has
since been overseei